Potential Role of a Novel Vascular Modulator, Hepatocyte Growth Factor (HGF), in Cardiovascular Disease: Characterization and Regulation of Local HGF System

スポンサーリンク

概要

• 論文の詳細を見る
• 1997-02-01

著者

• MORISHITA Ryuichi

  Department of Clinical Gene Therapy, Osaka University

• Nakamura Toshikazu

  Division Of Molecular Regenerative Medicine Graduate School Of Medicine Osaka University

• Masuo Kazuko

  Kagawa University

• MATSUMOTO Kunio

  Division of Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University

• Aoki Motokuni

  Department Of Clinical Gene Therapy Osaka University Graduate School Of Medicine

• Masuo Kazuko

  Nucleus Network Ltd. Baker Idi Heart And Diabetes Institute

• Morishita Ryuichi

  Division Of Gene Therapy Science Osaka University Graduate School Of Medicine

• MORIGUCHI Atsushi

  Department of Geriatric Medicine, Osaka University Medical School

• TOMITA Naruya

  Department of Geriatric Medicine, Osaka University Medical School

• Moriguchi Atsushi

  Department Of Geriatric Medicine Osaka University Graduate School Of Medicine

• Hayashi Shin-ichiro

  Department Of Cell Signaling Gifu University Graduate School Of Medicine

• Tomita Naruya

  Division Of Nephrology Department Of Internal Medicine Kawasaki Medical School

• Tomita Naruya

  Department Of General Medicine Osaka University Graduate School Of Medicine

• Tomita Naruya

  Osaka University Graduate School Of Medicine

• Matsushita Hidetsugu

  Department of Geriatric Medicine, Osaka University

• Nakamura Shigefumi

  Department Of Geriatric Medicine, osaka University

• Kohno Masakazu

  Second Department Of Internal Medicine Kagawa University

• Matsumoto Kunio

  Division Of Biochemistry Biomedical Research Center Osaka University Medical School

• Morishita Ryuichi

  Department Of Clinical Gene Therapy

• Nakamura Toshikazu

  Division Of Biochemistry Biomedical Research Center Omaha University Medical School

• Nakamura Shigefumi

  Department Of Geriatric Medicine Osaka University Medical School

• Matsumoto Kunio

  Department Of Nephrology Tokyo Medical University Ibaraki Medical Center

• Matsushita Hidetsugu

  Department Of Geriatric Medicine Osaka University

• Matsumoto Kunio

  Division Of Biochemistry Biomedical Research Center Osaka University Medical Center

• Hayashi Shinnichiro

  Department Of Cell Signaling Gifu University Graduate School Of Medicine

• Matsumoto Kunio

  Division Of Bichemistry Biomedical Research Center Osaka University Medical School

• Nakamura Toshikazu

  Division Of Bichemistry Biomedical Research Center Osaka University Medical School

• Morishita Ryuichi

  Department Cf Clinical Gene Therapy Graduate School Of Medicine Osaka University

関連論文

• Characteristics of Chronic Rejection in Heart Transplantation : Important Elements of Pathogenesis and Future Treatments
• Does therapeutic angiogenesis overcome CKD?
• The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension
• Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats
• Genetic basis of hypertension for the development of tailored medicine
• DPJ-013 Hepatocyte Growth Factor Attenuates TGF-β1 Angiotensin II Crosstalk by Down Regulation of Angiotensin II Type 1 Receptor through PTEN/Akt Pathway(DPJ03,Kidney/Renal Circulation/CKD (H),Digital Poster Session (Japanese),The 73rd Annual Scientific M
• Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer
• Serum hepatocyte growth factor concentration is a specific marker of endothelial dysfunction in humans
• Low-Dose Doxazosin Imoroved Aortic Stiffness and Endothelial Dysfunction as Measured by Noninvasive Evaluation
• The role of sympathetic nervous activity in renal injury and end-stage renal disease
• Leptin-Receptor Polymorphisms Relate to Obesity through Blunted Leptin-Mediated Sympathetic Nerve Activation in a Caucasian Male Population
• Anti-Aging Medicine in Cardiovascular Disease
• Lack of Association between the Hepatocyte Growth Factor Receptor, c-met, and the Anti-Apoptotic Action of Bag-1 in Endothelial Cells
• Gene-Modified Cell Transplantation Therapy Expressing hHGF and TK Produces Arteriolar Level Angiogenesis in Murine Hind Limb Ischemia
• Angiogenic gene cell therapy using hepatocyte growth factor improves ischemic limb
• High Plasma Norepinephrine Levels Associated with β2-Adrenoceptor Polymorphisms Predict Future Renal Damage in Nonobese Normotensive Individuals
• β2- and β3-Adrenoceptor Polymorphisms Relate to Subsequent Weight Gain and Blood Pressure Elevation in Obese Normotensive Individuals
• OE-318 Geneic Variants of Adrenoceptors Play Key Roles in the Pathogenesis of Hypertension and Obesity(Hypertension, clinical-2 (H) OE54,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
• Recovery of Learning and Memory by Gene Therapy Using Hepatocyte Growth Factor Gene After Focal Cerebral Ishcemia in Rats(Gene Therapy/Genetic Engineering (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Inhibitory Effect of Chimera Decoy Oligodeoxynucleotides (ODN) against Ets and NFκ B on the Progression of Rabbit Experimental Aortic Aneurysms (AAA)
• Gene Therapy for Abdominal Aortic Aneurysm (AAA) using Decoy Strategy against ets binding site
• Effect of E2F decoy on inhibitation of neointima formation in pig coronary arteries after balloon injury and stent implantation
• Transcription factor, ets-1, is a novel angiogenic molecule : Implication to ciene therapy to treat peripheral arterial disease
• Novel molecular intervention to treat abdominal aortic aneurysms (AAA) using chimera decoy oligodeoxynucleotides (ODN) against ets and NFkB binding sites
• Hepatocyte Growth Factor Enhancement of Preneoplastic Hepatic Foci Development in Rats Treated with Diethylnitrosamine and N-Ethyl-N- hydroxyethylnitrosamine
• Increase in DNA Synthesis of Cardiac Myocytes by Transfection ofP53 and Rb Antisense : Possibility of Cardiac Myocytes Regeneration
• Coexpression of hepatocyte growth factor and c-Met protooncogene product in synovial sarcoma
• FRS-003 Docking Protein Gab1 is Essential for HGF-dependent Endothelial Signaling and Angiogenesis after Hindlimb Ischemia(FRS1,New Molecules for Cardiovascular Regulation (M),Featured Research Session (English),The 73rd Annual Scientific Meeting of The J
• Expression of c-met/HGF Receptor in Human Non-small Cell Lung Carcinomas in vitro and in vivo and Its Prognostic Significance
• PE-062 Zyxin Progresses Epithelial-Mesenchymal Transition under the Control of Twist1 and Contributes to Endocardial Morphogenesis(PE011,Congenital Heart Disease (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation S
• The challenge of stopping the knocking down of metabolic dominos upstream
• OE-137 Pivotal Roles of Inflammatory Factors in Arteriosclerosis and its Specific Regulation(Infection/Inflammation/Immunity-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• FRS-117 An Initial Result of 2-Year Follow Up of 17 Clinical Cases With an NF-κ B Decoy Transfection at the Coronary Stenting(Coronary Revascularization (clinical) 2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Initial Clinical Cases of the Use of a NF-κB Decoy at the Site of Coronary Stenting for the Prevention of Restenosis
• PJ-086 Regression of Experimental Rabbit Aortic Aneurysm by The Treatment with Chimera Decoy Oligodeoxynucleotides (ODN) against ets and NFkB(Gene Therapy 1 (IHD) : PJ15)(Poster Session (Japanese))
• OJ-094 Delayed Post-ischemic Treatment with Fluvastatin Improved Learning and Memory Deficit After Stroke in Rats without affecting Infarction Volume(Cerebrovascular circulation / Stroke-1, The 71st Annual Scientific Meeting of the Japanese Circulation So
• PJ-652 Over-expression of HGF Improves Learning and Memory and Prevents Progressive Shrinkage of Thalamus in the Chronic Stage of Cerebral Infarction(Cerebrovascular circulation/Stroke-3 (H) PJ110,Poster Session (Japanese),The 70th Anniversary Annual Scie
• PJ-740 Hepatocyte Growth Factor (HGF), but not Vascular Endothelial Growth Factor (VEGF), Attenuated Ang II-induced EC Senescence by Inhibiting PIP3/rac1 Activity(PJ124,Peripheral Cirulation/Vascular Disease (Therapy) 4 (H),Poster Session (Japanese),The 7
• OJ-060 Hepatocyte Growth Factor Attenuate Ang II-induced Inflammation and Proliferation of Smooth Muscle Cell through EGF Receptor Degradation(OJ10,Atherosclerosis, Basic (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanes
• Coexpression of HGF and c-Met/HGF receptor in human bone and soft tissue tumors
• Hepatocyte Growth Factor(HGF) as a Potential Index of Severity of Hypertension
• IS033 UP-REGULATION OF KEY TRANSCRIPTIONAL FACTOR FOR ANGIOGENESIS, ETS, AND INDUCTION OF ANGIOGENESIS BY IN VIVO GENE TRANSFER OF HUMAN HEPATOCYTE GROWTH FACTOR (HGF) INTO MYOCARDIUM
• IS028 GENE THERAPY OF RESTENOSIS BY IN VIVO GENE TRANSFER OF HUMAN HEPATOCYTE GROWTH FACTOR (HGF) THROUGH THE ACCELATION OF RE-ENDOTHELIALIZATION
• Contribution of a Vascular Modulator, Hepatocyte Growth factor (HGF), to the Pathogenesis of Cardiovascular Disease
• IS053 ANTI-APOPTOTIC ACTION OF HEPATOCYTE GROWTH FACTOR ON HUMAN AORTIC ENDOTHELIAL CELLS
• Potential Role of a Novel Vascular Modulator, Hepatocyte Growth Factor (HGF), in Cardiovascular Disease: Characterization and Regulation of Local HGF System
• 2 Estrogen Decreases the Activation of RANK-RANKL System in Vascular Calcification(Young Investigator's Award for International Students Finalists Lecture (YIA International),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• PJ-477 A Therapeutic Strategy to Treat Brain Ischemia : Over-expression of Hepatocyte Growth Factor Gene Reduced Ischemic Injury in Rat Model(Cerebrovascular Circulation/Stroke 1 (H) : PJ80)(Poster Session (Japanese))
• PJ-345 Hepatocyte Growth Factor Attenuates Angiotensin II Induced Renal Fibrosis through TGF-B Suppression by Anoikis of Myofibroblasts(Kidney/Renal circulation(06)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation
• PJ-762 Requirement of HIF-1a Signaling on the Expression of Nkx2.5 for Normal Heart Developement in Xenopus(Development and differentiation-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• PE-114 Angiotensin II Blocker, Valsartan, Supresses the Development of Experimental Abdominal Aortic Aneurysm in Rats(Peripheral circulation/Vascular disease(03)(H),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Soc
• Regulation of Invasive Potential of Human Prostate Cancer Cell Lines by Hepatocyte Growth Factor
• Gene Transfer of Hepatocyte Growth Factor Improves the Development of Experimental Autoimmune Myocarditis through Induction of T Helper 2 Cells(Gene Therapy 2 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Differences in Mechanisms between Weight Loss-Sensitive and-Resistant Blood Pressure Reduction in Obese Subjects
• Sympathetic Activity and Body Mass Index Contribute to Blood Pressure Levels
• P683 SYMPATHETIC HYPERACTIVITY AND HYPERINSULINEMIA ARE RELATED WITH OBESE-INDUCED BP ELEVATION IN YOUNG SUBJECTS
• P230 EFFECTS OF AGE ON PREVALENCE OF HYPERINSULINEMIA IN NON-OBESE JAPANESE MEN
• P708 FREQUENCY OF DEVELOPMENT OF ESTABLISHED HYPERTENSION FROM THE BORDERLINE HYPERTENSIVES IN A 10-YEAR PERIOD IN JAPANESE MEN
• 1174 CAPTOPRIL AND NIFEDIPINE-RETARD REDUCE THE PREVALENCE OF ORTHOSTATIC HYPOTENSION IN ELDERLY HYPERTENSIVE PATIENTS
• -1040- COMPARISONS OF DYSLIPIDEMIA AND INSULIN RESISTANCE BETWEEN THE YOUNG SUBJECTS WITH AND WITHOUT FAMILY HISTORY OF HYPERTENSION(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
• Hormonal Mechanisms in Blood Pressure Reduction during Hemodialysis in Patients with Chronic Renal Failure
• DO REDUCED INSULIN SENSITIVITY AND DYSLIPIDEMIA EXIST IN BORDERLINE HYPERTENSIVE PATIENTS?
• THE FREQUENCY OF ORTHOSTATIC HYPOTENSION IN ELDERLY PATIENTS WITH ESTARLISHED HYPERTENSION(EHT),iSOLATED SYSTOLIC HYPERTENSION(SHT) AND BORDERLINE HYPERTENSION(BHT)
• THE DIFFERENCES IN INSULIN SENSITIVITY BETWEEN BEFORE AND AFTER DRUG MEDICATION BY CALCIUM ANTAGONIST(NIFEDIPINE)IN ESSENTIAL HYPERTENSIVE PATIENTS
• PJ-691 Inhibition of Development of Experimental Aortic Abdominal Aneurysm in Rat Model by Atorvastatin through Inhibition of Macrophage Migration(Peripheral circulation/Vascular disease-6, The 71st Annual Scientific Meeting of the Japanese Circulation So
• PE-543 Inhibiton of Experimental Aortic Abdominal Aneurysm by Angiotensin Receptor Blocker, Valsartan(Peripheral circulation/Vascular disease-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Two Years Follow-up of Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease Using Hepatocyte Growth Factor Gene Transfer(Peripheral Circulation/Vascular Disease (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Clinical Trial of Human Gene Therapy Using Hepatocyte Growth Factor Gene Transfer(Translational Research in Cardiovascular Disease, The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• FRS-013 Long Term Evaluation of Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease Using Hepatocyte Growth Factor Gene Transfer(Angiogenesis and Regeneration Medicine in Cardiovascular Medicine (M) : FRS3)(Featured Research Session (Engl
• Increase in Peripheral Blood Flow by Intravenous Administration of Prostaglandin E1 in Patients with Peripheral Arterial Disease, Accompanied by Up-Regulation of Hepatocyte Growth Factor
• Inhibition of Restenosis by Beraprost Sodium (a Prostaglandin 12 Analogue) in the Porcine Coronary Artery after Angioplasty
• Results of Safety from Human Clinical Gene Therapy Using HGF (TREAT-HGF)
• Long Term Evaluation of Results from the First Stage in the Clinical Trial of Gene Therapy for Peripheral Arterial Disease
• Clinical Results of TREAT-HGF (Japan Trial to Treat Peripheral Arterial Disease by Therapeutic Angiogenesis Using Hepatocyte Growth Factor Gene Transfer)
• Evaluation of utility of prostagrandin E1 in the patients with ASO : Protective effect on endothelial function through up-regulation of HGF
• No increase in human HGF concentration in the patients transfected with human HGF plasmid : preliminary clinical results from TREAT-HGF
• Preliminary clinical results from TREAT-HGF (Japan Trial to Treat Peripheral Arterial Disease by Therapeutic Angiogenesis Using HGF Gene Transfer)
• OJ-213 Prevention of Abdominal Aortic Aneurysm using Ribbon-type Chimeric Decoy Oligodeoxynucleotides against NF κ B and Ets in a Rat Model(Genetics/Genetically engineered models/Gene therapy-2(H/M), The 71st Annual Scientific Meeting of the Japanese Circ
• OJ-028 Role of NF κ B and Ets in Development of Abdominal Aortic Aneurysm in Human(Peripheral circulation/Vascular disease-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Overexpression of HGF (Hepatocyte Growth Factor) Reduced Ischemic Injury in Rat Permanent Middle Cerebral Artery Occlusion (MCAO) Model
• Therapeutic Angiogenesis Induced by Transfection of Hepatocyte Growth Factor (HGF) Gene in Porcine Myocardial Infarction Model
• Hepatocyte Growth Factor as Cardiovascular Hormone: Role of HGF in the Pathogenesis of Cardiovascular Disease
• Hepatocyte Growth Factor in Mouse Soleus Muscle Increases with Reloading after Unloading
• Expression of Hepatocyte Growth Factor in Rat Skeletal Muscle
• Novel Molecular Therapeutic Approach to Cardiovascular Disease Based on Hepatocyte Growth Factor (HGF)
• Acquisition of Invasive Phenotype in Gallbladder Cancer Cells via Mutual Interaction of Stromal Fibroblasts and Cancer Cells as Mediated by Hepatocyte Growth Factor
• Induction of Invasive Growth in a Gallbladder Cancer Cell Line by Hepatocyte Growth Factor in vitro
• Stimulation of Hepatocyte Growth Factor Production by Heparin-derived Oligosaccharides
• Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS
• Systemic NK4 gene therapy inhibits tumor growth and metastasis of melanoma and lung carcinoma in syngeneic mouse tumor models
• In vivo Gene Transfer for the Therapy of Vascular Diseases
• Up-regulation of integrin β3 in radioresistant pancreatic cancer impairs adenovirus-mediated gene therapy
• Novel Function of Prostaglandins as Inducers of Gene Expression of HGF and Putative Mediators of Tissue Regeneration^1
• 4 Strategy of Anti-aging in Adult Common Disease : Association of Hypertension, Metabolic Syndrome and Osteoporosis(Lifestyle-related Diseases and Signalling Networks in Aging,Topic 7 (TP-7) (H),The 73rd Annual Scientific Meeting of The Japanese Circulati
• The role of hepatocyte growth factor in growth plate cartilage
• THE ROLE OF HGF/SF IN CARTILAGE DEVELOPMENT
• IS026 Hypoxia Induced Endothelial Apoptosis Through the Activation of NFkB : In Vivo Evidence of Importance of NFkb in Endothelial Cell Regulation
• Effects of weight loss on renal function in overweight Japanese men
• Association between osteopontin promoter variants and diastolic dysfunction in hypertensive heart in the Japanese population
• Different mechanisms in weight loss-induced blood pressure reduction between a calorie-restricted diet and exercise

もっと見る 閉じる

スポンサーリンク